The effect of neuropeptide Y on cell survival and neurotrophin expression in in-vitro models of Alzheimer’s disease

Author： Angelucci Francesco   Gelfo Francesca   Fiore Marco   Croce Nicoletta   Mathé Aleksander A.   Bernardini Sergio   Caltagirone Carlo  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.92, Iss.8, 2014-01, pp. : 621-630

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Alzheimer’s disease: transgenic mouse models and drug assessment

By Yu P.   Oberto G.  

Pharmacological Research, Vol. 42, Iss. 2, 2000-08 ,pp. : 107-114

Academic Press

Access to resources Recommend Favorite

Alzheimer’s Disease

By  

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite

Subcellular Injuries in Alzheimer’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 4, 2014-06 ,pp. : 593-605

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s disease and related dementias:

By Williams M.   Davis R.E.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 6, 1997-06 ,pp. : 735-759

Informa Healthcare

Access to resources Recommend Favorite

Ongoing trials in Alzheimer’s disease

By Sramek J.J.   Cutler N.R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 899-915

Informa Healthcare

Access to resources Recommend Favorite